Annual Report · 10-K
VERADIGM INC
MDRXOTCEQUITYCurrent
Annual Report
Filed May 26, 2026Accepted May 26, 2026, 4:29 PM EDTCIK 1124804Accession 0001193125-26-239413
Company context
Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system. © 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.
Current securities
Historical securities (1)
Registered securities in this filing
VERADIGM INC. · 10-K · Filed 2026-05-26
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, par value $0.01 per share
- Symbol
- MDRX
- Exchange
- Not supplied
- Classification
- COMMON
Filing context
Context: C_363e76f8-fdf7-46da-a2e4-cea2812fe6d8
Dimensions: us-gaap:StatementEquityComponentsAxis
Preferred Stock Purchase Rights
- Symbol
- Not supplied
- Exchange
- Not supplied
- Classification
- RIGHT
Filing context
Context: C_b539f90b-6da7-4a9a-b4fe-f1e1865223be
Dimensions: us-gaap:StatementEquityComponentsAxis
Accession 000119312526239413 · 2 registered-security cover members
Read the exact SEC filing ↗As-filed source
Primary evidence